Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus metoprolol added to thiopental during electroconvulsive therapy in adults with mood disorder
IRCT20141209020258N87Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine, metoprolol and thiopental in affective disorder (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Mean blood pressure, Heart rate and 3 more. Started May 2018; status: completed.
02
Drugs
dexmedetomidinemetoprololthiopental
03
Conditions
affective disorder
Beyond the preview
Go deeper on IRCT20141209020258N87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N87.